Innoviva, Inc. (NASDAQ: INVA)
$17.2400
-0.0700 ( +0.64% ) 122.5K
Innoviva Inc is a company with a portfolio of royalties and innovative healthcare assets. It has three primary sets of assets: a royalty portfolio, operating assets in critical care and infectious disease, and other strategic healthcare assets. Its product offering includes Relvar/Breo/Ellipta, Anoro, Ellipta, Trelegy, Ellipta and others.
Market Data
Open
$17.2400
Previous close
$17.3100
Volume
122.5K
Market cap
$1.07B
Day range
$17.0510 - $17.2950
52 week range
$14.3250 - $21.2800
SEC Filings
Form Type | Description | Pages | Date |
---|---|---|---|
4 | Insider transactions | 1 | Nov 22, 2024 |
8-k | 8K-related | 15 | Nov 06, 2024 |
10-q | Quarterly Reports | 82 | Nov 06, 2024 |
4 | Insider transactions | 1 | Aug 22, 2024 |
8-k | 8K-related | 15 | Jul 31, 2024 |
10-q | Quarterly Reports | 76 | Jul 31, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |
4 | Insider transactions | 1 | Jun 20, 2024 |